THYROID DIN 00023965
Health Canada record
| Active ingredient(s) | THYROID 125 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | H03AA05 THYROID GLAND PREPARATIONS |
| Original market date | 31-Dec-1951 |
| Current status date | 04-Oct-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Searchlight Pharma Inc — licence 102247, currently licensed, last inspection rating C (2024-10-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing THYROID
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00023957 | THYROID | SEARCHLIGHT PHARMA INC | Tablet | THYROID 60 MG | Marketed |
| 00023949 | THYROID | SEARCHLIGHT PHARMA INC | Tablet | THYROID 30 MG | Marketed |
| 02499401 | ERFA THYROID | ERFA CANADA 2012 INC | Tablet | THYROID 30 MG | Cancelled Pre Market |
| 02499428 | ERFA THYROID | ERFA CANADA 2012 INC | Tablet | THYROID 60 MG | Cancelled Pre Market |
| 02499436 | ERFA THYROID | ERFA CANADA 2012 INC | Tablet | THYROID 125 MG | Cancelled Pre Market |
| 02233760 | THYROIDINUM | SEROYAL INTERNATIONAL INC. | Tablet; Globules; Pellet; Drops; Liquid; Granules | THYROID 6 X | Cancelled Post Market |
International API supply for THYROID
6 active FDA Drug Master Files.
Request a quote for THYROID